Literature DB >> 1391991

Making the most of your prognostic factors: presenting a more accurate survival model for breast cancer patients.

K L Knorr1, S G Hilsenbeck, C R Wenger, G Pounds, T Oldaker, P Vendely, M R Pandian, D Harrington, G M Clark.   

Abstract

Determining an appropriate level of adjuvant therapy is one of the most difficult facets of treating breast cancer patients. Although the myriad of prognostic factors aid in this decision, often they give conflicting reports of a patient's prognosis. What we need is a survival model which can properly utilize the information contained in these factors and give an accurate, reliable account of the patient's probability of recurrence. We also need a method of evaluating these models' predictive ability instead of simply measuring goodness-of-fit, as is currently done. Often, prognostic factors are broken into two categories such as positive or negative. But this dichotomization may hide valuable prognostic information. We investigated whether continuous representations of factors, including standard transformations--logarithmic, square root, categorical, and smoothers--might more accurately estimate the underlying relationship between each factor and survival. We chose the logistic regression model, a special case of the commonly used Cox model, to test our hypothesis. The model containing continuous transformed factors fit the data more closely than the model containing the traditional dichotomized factors. In order to appropriately evaluate these models, we introduce three predictive validity statistics--the Calibration score, the Overall Calibration score, and the Brier score--designed to assess the model's accuracy and reliability. These standardized scores showed the transformed factors predicted three year survival accurately and reliably. The scores can also be used to assess models or compare across studies.

Entities:  

Mesh:

Year:  1992        PMID: 1391991     DOI: 10.1007/bf01840838

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  1 in total

1.  DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.

Authors:  C R Wenger; S Beardslee; M A Owens; G Pounds; T Oldaker; P Vendely; M R Pandian; D Harrington; G M Clark; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1993-10       Impact factor: 4.872

  1 in total
  2 in total

1.  Prognostic value of poorly differentiated clusters in invasive breast cancer.

Authors:  Ying Sun; Fenli Liang; Wei Cao; Kai Wang; Jianjun He; Hongyan Wang; Yili Wang
Journal:  World J Surg Oncol       Date:  2014-10-12       Impact factor: 2.754

Review 2.  Survival analysis part IV: further concepts and methods in survival analysis.

Authors:  T G Clark; M J Bradburn; S B Love; D G Altman
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.